Product News


New anti-cemiplimab (Libtayo) antibodies that inhibit PD-1 binding. Select conjugated anti-drug antibodies ready for bioanalysis and drug-monitoring assays.


Bio-Rad launched Bio-Plex SARS-CoV-2 Variant Neutralization Antibody Assays for RUO that help to efficiently measure neutralizing antibodies against wild-type & SARS-CoV-2 variants.


StarBright UltraViolet 400 Dye Offers Maximal Brightness and Narrow Excitation and Emission Profiles for Precise Resolution


The CFX Opus 96 Dx System and the CFX Opus 384 Dx Real-Time PCR Systems Offer Accurate and Precise Quantification to Improve IVD Assay Development and Diagnostic Testing


The Panels Complete Bio-Rad’s Set of Bio-Plex Multiplex SARS-CoV-2 Human Serology Panels for Detection of Antibodies Against Four SARS-CoV-2 Antigens


Labs in Europe that perform standard COVID-19 testing can now test for SARS-CoV-2, influenza A, and influenza B simultaneously during the flu season, using the Reliance SARS-CoV-2/FluA/FluB™ RT-PCR Kit (IVD).


The solution includes chromogenic medium and a selective supplement that can detect these bacteria without the need for a confirmation step, delivering results in less than 24 hours.

The StarBright Violet 570, StarBright Violet 670, and StarBright Violet 710 Dyes offer improved brightness and resolution.
The kit improves assay efficiency by eliminating irrelevant RNA fragments from an RNA-Seq library.
The real-time reverse-transcription PCR (RT-PCR) assay kit can detect nucleic acid in SARS-CoV-2, the virus associated with COVID-19 disease.